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Abstract
We assessed the effects of low dose methamphetamine treatment of traumatic brain injury (TBI) in rats by employing MRI,
immunohistology, and neurological functional tests. Young male Wistar rats were subjected to TBI using the controlled
cortical impact model. The treated rats (n = 10) received an intravenous (iv) bolus dose of 0.42 mg/kg of methamphetamine
at eight hours after the TBI followed by continuous iv infusion for 24 hrs. The control rats (n = 10) received the same volume
of saline using the same protocol. MRI scans, including T2-weighted imaging (T2WI) and diffusion tensor imaging (DTI), were
performed one day prior to TBI, and at 1 and 3 days post TBI, and then weekly for 6 weeks. The lesion volumes of TBI
damaged cerebral tissue were demarcated by elevated values in T2 maps and were histologically identified by hematoxylin
and eosin (H&E) staining. The fractional anisotropy (FA) values within regions-of-interest (ROI) were measured in FA maps
deduced from DTI, and were directly compared with Bielschowsky’s silver and Luxol fast blue (BLFB) immunohistological
staining. No therapeutic effect on lesion volumes was detected during 6 weeks after TBI. However, treatment significantly
increased FA values in the recovery ROI compared with the control group at 5 and 6 weeks after TBI. Myelinated axons
histologically measured using BLFB were significantly increased (p,0.001) in the treated group (25.8461.41%) compared
with the control group (17.0562.95%). Significant correlations were detected between FA and BLFB measures in the
recovery ROI (R = 0.54, p,0.02). Methamphetamine treatment significantly reduced modified neurological severity scores
from 2 to 6 weeks (p,0.05) and foot-fault errors from 3 days to 6 weeks (p,0.05) after TBI. Thus, the FA data suggest that
methamphetamine treatment improves white matter reorganization from 5 to 6 weeks after TBI in rats compared with
saline treatment, which may contribute to the observed functional recovery.
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Introduction
Traumatic brain injury (TBI) is a leading factor of morbidity
and mortality in Western countries [1,2], and an important public
health problem. There is an urgent need to develop a novel
approach for the treatment of TBI, that can restore brain function.
TBI produces a primary insult, which may trigger widespread
brain damage regardless of the original site of injury [3]. Thus,
patients with TBI may suffer from axonal degeneration and
generalized cerebral atrophy associated with poor neurological
functions [4–8]. Unfortunately, the management of patients with
TBI to-date has primarily focused on therapeutic intervention
designed to reduce cellular damage and brain edema [9];
currently, no effective clinical treatment can repair biostructural
damage to the neurons and prevent or reduce secondary
pathological processes [10]. However, experimental pharmaco-
logical and cell-based treatments of TBI which promote brain
remodeling have shown promising results in improving functional
recovery after TBI in animals [11–15].
Methamphetamine is a potent psychostimulant that alters the
release and reuptake of dopamine, norepinephrine, and serotonin.
Large doses of methamphetamine result in neuronal toxicity and
the induction of cell death throughout the brain [16]. However,
low dose methamphetamine may be protective after oxygen
glucose deprivation by decreasing excitatory synaptic potential,
and prevents cell death by modulating cytokines and neurotrophic
factors [17,18]. Recently, in a lateral fluid percussion injury model
of rat, low dose methamphetamine treatment at three hours after
TBI significantly increased the presence of immature neurons, and
reduced apoptotic cell death, as well as improved both behavioral
and cognitive dysfunctions [15].
Prior methamphetamine studies focused on histological in-
vestigation [15,17,18]. The therapeutic effects of low dose
methamphetamine treatment of TBI can be dynamically morni-
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tored and longitudinally investigated using magnetic resonance
imaging (MRI) [19,20]. MRI, including T2-weighted imaging
(T2WI), susceptibility weighted imaging (SWI), diffusion tensor
imaging (DTI) and cerebral blood flow (CBF) measurement with
the arterial spin labeling (ASL) technique, provides a preferable
way to track biostructural damage and changes of the brain after
TBI [19,20]. DTI permits assessment of diffuse axonal injury after
brain injury [21–23]. Fractional anisotropy (FA) deduced from
DTI is reduced in major white matter tracts in the central areas of
the injured brain [21,22], and is increased in the recovery regions
surrounding the impact core after cell-based treatment of TBI in
rats. This increase in FA has been attributed to axonal remodeling
and increased oligodendrocyte generation [19]. Thus in the
present study, we employed MRI to assess the effects of low dose
methamphetamine treatment on neuronal recovery following
a controlled cortical impact (CCI) model of TBI in rats.
Materials and Methods
All experimental procedures were conducted and performed in
accordance with guidelines for animal research under a protocol
approved by the Institutional Animal Care and Use Committee of
Henry Ford Hospital (No.1051). MRI scan and data analysis, TBI
surgery and methamphetamine treatment, neurobehavioral func-
tional tests and histological measurements, were performed in
a double-blind fashion. Three rats died within the 6 week test
period and before completion of all MRI scans and were excluded
from measurement and analysis.
TBI Model
Young male Wistar rats (Charles River, Wilmington, MA)
weighing 200–300 g at arrival were kept at the animal facility for 7
days before initiating the experiments. Rats were anesthetized with
chloral hydrate (350 mg/kg). Body temperature was maintained at
37uC with a feedback-regulated water recirculating pad. Blood
gases and blood pressure were monitored during the surgical
procedure by placing PE-50 catheters into the femoral artery and
vein to obtain blood. The head of each rat was then mounted in
a stereotaxic frame in a prone position and secured by ear bars
and an incisor bar. Two 10 mm-diameter craniotomies were
performed adjacent to the central suture, midway between the
lambda and the bregma, leaving the dura mater over the cortex
intact. The left craniotomy confined the location of experimental
impact while the right one allowed for the lateral movement of
cortical tissue. Injury was induced by a pneumatic impact device
[24] on the intact dura. A single strike was delivered at 4 m/sec
with a 2.5 mm of compression to the left cortex with a pneumatic
piston containing a 6 mm-diameter tip. After the impact, the bone
plate was not replaced and was sealed with bone wax, the skin was
then sutured with 4-0 surgical thread. Buprenex (0.05 mg/kg) was
subcutaneously administered to animals after brain injury for
analgesia. This animal model is a clinically relevant model of TBI,
which produces a severe TBI with contusion lesion affecting part
of the motor and primary somatosensory cortex, and has been
used for many years [25]. Animals were provided with 10 mL
warmed saline via subcutaneous injection immediately after
surgery and monitored 3–4 times daily within the first 48 hours
following the insult and had free access to food and water.
Methamphetamine Treatment
Eight hours after the TBI, rats were anesthetized by isofluorane
inhalation. An incision was made at the inguinal crease to expose
the femoral vein. An Alzet osmotic pump (DURECT Corp,
Cupertino, CA) connected to a catheter was placed within the
crease with the catheter extending from the pump and placed into
the femoral vein. The incision was closed with 4-0 vicryl sutures.
One group of rats, referred to as the treated group (n= 10), were
treated with a bolus dose of 0.42 mg/kg methamphetamine via the
saphenous vein followed by continuous infusion intravenously (iv)
with 0.05 mg/kg/hr for 24 hrs. Animals, assigned as the control
group (n= 10), received the same volume of saline as bolus iv dose
followed by continuous iv infusion with 6.6mL/hr for 24 hrs. At 48
hours after pump placement, rats were again briefly anesthetized
with isoflurane, the pump and femoral vein catheter were
removed, and the incision in the inguinal area was sutured with
4-0 absorbable suture and sealed with skin glue.
MRI Measurements
MRI measurements were performed with ClinScan 7T system,
which combines Bruker-Biospin hardware (Bruker-Biospin, Ettlin-
gen, Germany) interfaced to Siemens software, Syngo (Siemens,
Erlanger, Germany). A birdcage type coil was used as transmitter
and a quardrature half-volume coil as receiver. MRI scans were
performed one day before TBI, 1 and 3 days post TBI and then
weekly for 6 weeks. Pulse sequences included T2WI, SWI, and
DTI. A fast gradient echo imaging sequence was used for
reproducible positioning of the animal in the magnet at each
MRI session. Stereotactic ear bars were used to minimize
movement during the imaging procedure. During MRI measure-
ments, anesthesia were maintained using medical air (1.0 L/min)
and isoflurane (1.0–1.5%). Rectal temperature was maintained at
37uC using a feedback controlled water bath.
T2WI was acquired using a Carr-Purcell-Meiboom-Gill multi-
slice and multiecho (six echoes) sequence. A series of six sets of
images (13 slices for each set) were obtained using echo times (TEs)
of 15, 30, 45, 60, 75, and 90 ms and a repetition time (TR) of
4.5 sec. Images were produced using a 32632 mm2 field-of-view
(FOV), 1 mm slice thickness, 1286128 image matrix. T2 map was
obtained by exponentially fitting the six images pixel-by-pixel with
different echo times for each slice. SWI employed a specialized 3-
dimensional gradient echo sequence with TE=10 ms,
TR=40 ms, flip angle of 15u, 32632624 mm3 FOV,
2566192664 matrix (a resolution of 125mm6167mm6375mm),
and flow compensation in all three directions. DTI was acquired
using a spin-echo sequence with pulsed diffusion weighted
gradients and echo-planar readout. The field of view was
32632 mm2; 1286128 imaging matrix, 1 mm slice thickness with
13 slices, TR=10 s and TE=50 ms, 1 shot, 2 averages, 1 DTI
baseline of b = 0 s/mm2, 20 directions of diffusion gradients with
b= 900 and 1800 s/mm2, respectively, for each slice.
Ex vivo MRI Measurements
Q-ball based DTI [26] was performed using a pulsed gradient
spin echo sequence with the following parameters: 1286128
matrix; 32632 mm2 FOV; 1 mm slice thickness with 13 slices;
TR=1.5 s; TE= 38 ms; d=10 ms; D=18 ms; b = 900 s/mm2 at
128 directions and one baseline with b= 0; four signal average;
total acquisition time was approximate 27 hours for Q-ball
imaging.
Neurobehavioral Functional Tests
Neurological function was monitored by modified neurological
severity scores (mNSS) [27] and foot-fault test [28]. Baseline
neurological function was established for all animals prior to TBI
and again on days 1, 7, 14, 21, 28, 35, and 42 post brain injury.
On day 38 to day 42 following TBI, the Morris Water Maze
(MWM) test was performed to assess the impact of methamphet-
amine on cognitive function (learning and memory) [29].
MRI of Methamphetamine Treated TBI Rats
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Immunohistochemical Staining
Animals were euthanized after completing the last MRI
measurements and functional tests at 42 days post TBI. Rats
were anesthetized with intraperitoneal injection with chloral
hydrate, and perfused transcardially with saline, followed by 4%
paraformaldehyde. Brains were isolated, post-fixed in 4% para-
formaldehyde for 2 days at room temperature, and then processed
for paraffin sectioning. Using light microscopy and a laser
scanning confocal microscope (Zeiss LSM 510), we measured
a composite index of independent measurements from multiple
immunohistochemical stainings for axons (Bielschowsky’s silver
and Luxol fast blue, BLFB [30]; monoclonal antibody to non-
phosphorylated neurofilaments, SMI-32 [31]), dendrites (micro-
tubule-associated protein 2, MAP-2 [32]) and synapses (synapto-
physin, SYP [33]). Data were expressed as density, or percentage
of area of immunoreactive proteins, to the area of the FOV.
Lesion areas were measured as a percentage to the ipsilateral
hemisphere areas with hematoxylin and eosin, H&E [34],
immunohistochemical stained slices.
MRI Data and Statistical Analysis
MRI image analysis was generally performed with homemade
software, Eigentool [35]. Q-ball DTI analysis was performed using
Camino software [36].
The TBI lesion was identified on the MRI T2 map. The
ipsilateral lesion area on each slice of the T2 map was specified by
those pixels with a T2 value higher than the mean plus the twice
standard deviations provided by the normal tissue of the same
animal on the pre-TBI T2 map. Lesion volume was obtained by
adding all the areas measured on individual slices and multiplying
by the slice thickness. The volume of the lateral ventricle was
measured on T2 maps at a fixed structural location presented by
four contiguous coronal T2 slices using the same criterion as
described above to identify the ventricular area on each slice. The
ventricular volume was obtained by adding all the areas measured
on individual slices and multiplying by the slice thickness.
Two MRI regions of interest (ROI) were identified as the TBI
core and recovery areas for analysis of MRI parameters. The first
ROI, referred to as, the TBI core, was demarcated on the T2 map
obtained 6 weeks after TBI, by using the T2 value threshold of
mean plus two standard deviations based on the T2 value
measured in the pre-TBI T2 map for each animal [19]. The
second ROI, referred as the, TBI recovery area [19], was
demarcated by subtracting the TBI core from the TBI lesion area
in T2 maps obtained 24 hrs after TBI.
SWI was employed to identify hemorrhagic lesions after TBI
and to demarcate the TBI lesion from the ventricle in rat brain
[20].
The FA map from DTI was first warped to the corresponding
T2 map; then, the TBI core and recovery ROIs obtained from the
same slice of T2 map were, respectively, loaded onto the FA map
for measurement. The present FA data were normalized to pre-
TBI FA values.
Diffusion standard deviation (SD) map [37], derived from Q-
ball imaging, was created based on calculating the deviation of
diffusivity from a sphere for each voxel in the image. If diffusion is
constrained by tubular structures, the SD will possess a non-zero
value based on the complexity of the structure [37].
A mixed model, analysis of variance (ANOVA) and covariance
(ANCOVA) was performed. The analysis started testing the
treatment group and time (without baseline time point) in-
teraction, followed by testing the group difference at each time
point, or the time effect for each treatment group, if the interaction
or the overall group/time effect was detected at the 0.05 level.
Subgroup analysis was followed to test the difference at each group
and time level using the paired two-tailed t-test. Two-sample t-test
was performed to check the balance of the data at the baseline, as
well as to test the treatment effect at day 42 post TBI for
histological evaluation. Pearson’s correlation analysis was applied
between MRI values obtained at 6 weeks after TBI and
histological measurements. MRI and histological measurements
are summarized as mean and standard error (SE).
Results
The lesion volumes of TBI damaged cerebral tissue were
demarcated by elevated values in T2 maps and measured at
24 hrs, 72 hrs and weekly from 1 to 6 weeks post TBI in rats. T2
maps of representative rats are shown in figure 1, which depict the
evolution of T2 values for a methamphetamine treated rat (the 1
st
row) and a saline treated rat (the 2nd row), respectively. Lesion
volumes at 24 hrs after TBI, 65.0368.54 mm3 for the treated rats
and 56.7165.15 mm3 for the control rats, exhibited no initial
statistical difference (p.0.41) between the two groups. At 6 weeks
after TBI, lesion volumes were 25.51612.14 mm3 for the treated,
and 32.4969.45 mm3 for the control, respectively, and no
statistical differences (p.0.65) were detected. Methamphetamine
treatment did not significantly reduce lesion volumes compared to
the controls during 6 weeks after TBI in rats, and the lesion
volumes are quantitated in Fig. 2 a.
The two lower rows of T2 maps in figure 1, from a metham-
phetamine treated rat (the 3rd row) and a saline treated rat (the 4th
row), respectively, exhibited the expansive profiles of cerebral
ventricles after TBI. Pre-TBI, the lateral ventricular volumes were
3.1260.09 mm3 in each hemisphere and were demarcated using
T2 maps. All animals exhibited similar ventricular volumes on
both hemispheres, and no differences were detected between the
two treatment groups. After TBI, ventricular volumes were
measured at 24 hrs, 72 hrs, and then weekly from 1 to 6 weeks.
No benefits of low dose methamphetamine treatment were
observed on reducing ventricular expansion in the treated rats,
compared to the controls (Fig. 2 b). At 6 weeks after TBI, the
ipsilateral ventricular volumes were measured and found to be
7.9361.29 mm3 for the treated rats, and 10.7163.32 mm3 for the
control animals. Correspondingly, in the contralateral side, the
ventricular values were 4.5561.00 mm3 for the treated and
5.2961.20 mm3 for the control groups. No significant differences
were detected between the two groups (p.0.45 for ipsilateral side,
p.0.64 for the other side).
The temporal profiles of FA values, normalized to pre-TBI
measurements, of the TBI core and recovery ROIs were
calculated (Fig. 2 c) and used for analysis. The FA values obtained
from the TBI core ROIs remained low within six weeks after TBI
for both control and treated groups, and no significant differences
were detected in FA measurements of the core regions between the
two groups. However, the FA values in the TBI recovery ROIs
increased during 6 weeks post TBI in both control and treated
groups. The methamphetamine treated group revealed larger
increases than the control group. Significant increases of FA values
obtained from the TBI recovery ROIs were detected between the
treated and control groups starting at 5 weeks after TBI. The
values of the normalized FA for treated and control groups were
1.1360.21 versus 0.946.09 at 5 w (p,0.03), and 1.2160.14
versus 1.0360.15 at 6 w (p,0.02), respectively, after TBI.
T2 values of cerebral tissue were measured in the TBI core and
recovery ROIs for all animals in the study (Fig. 2 d). There were
no significant differences between the methamphetamine and
saline treated animal groups for either TBI core or recovery
MRI of Methamphetamine Treated TBI Rats
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regions, respectively. The temporal changes of T2 values of injured
cerebral tissue, however, demonstrated a significant time effect
after TBI for both groups. Starting at 14 days post TBI, T2 values
of cerebral tissue were significantly different between the TBI core
and recovery regions for both animal groups throughout the 6
week measurement time (p,0.05).
For the immunohistochemical measurements, significant in-
creases in MAP-2 (Fig. 3 a, p,0.02) and SMI-32 (Fig. 3 b,
p,0.02) were observed in the ipsilateral TBI lesion boundary in
the treated rats with the values of 12.5862.12% (MAP-2) and
9.0962.25% (SMI-32), compared to the control rats with the
values of 9.9861.68% (MAP-2) and 7.3661.52% (SMI-32),
respectively. Moreover, BLFB stained axons and myelin, re-
spectively, (Fig. 3 c) were histologically measured in the TBI
boundary ROI for changes in cerebral white matter. A significant
increase (p,0.001) was detected in the treated group,
25.9461.41%, compared with control group, 17.0562.95%.
However, no significant differences were detected in synaptophy-
sin expression between the treated, 17.2765.44%, and the control
rats, 17.8265.44% (Fig. 3 d). Analysis of H&E sections, showed
percent lesion volumes of 10.464.8% for the treated rats and
14.365.2% for the control, and no differences were detected
between the two groups (p = 0.10).
A significant Pearson’s correlation was detected between
normalized FA values obtained at 6 weeks after TBI and
measurements of BLBF staining in TBI boundary ROI
(R= 0.54, p,0.02).
Reduced functional impairments were detected in the low dose
methamphetamine treated group as compared with the control
group. Significant improvements by methamphetamine treatment
were detected in mNSS from 2 to 6 weeks (p,0.05), as shown in
Fig. 4 a; and in foot-fault tests from 3 days to 6 weeks after TBI
(p,0.05), as shown in Fig. 4 c for the hindlimb and Fig. 4 d for the
forelimb. However, no significant improvement was detected with
Morris Water Maze test, see Fig. 4 b (p = 0.12).
Figure 5 shows ex-vivo MRI from a representative control rat
sacrificed at 6 weeks after TBI. The fiber orientation map, Fig. 5 a,
was derived from a Q-ball MRI scan. The area within the blue
frame is enlarged (Fig. 5 b), and indicates well-oriented fibers (few
crossing patterns) in cortex (blue and yellow arrow heads)
surrounding the TBI lesion core, that is referred to as the T2
map (cyan arrow in Fig. 5 e). With elevated values, both SD (Fig. 5
c) and FA (Fig. 5 d) maps identified the white matter fiber tracts
along two sides of the lesion core (blue and yellow arrow heads in
Fig. 5 c & d), and the FA map exhibited a higher image contrast
than the SD map. The areas with reduced differences between FA
and SD maps may reflect the reorganization of axonal fibers
taking place after TBI, and the well organized fibers were oriented
in a single direction. These MRI outcomes were consistent with
the histological results obtained with BLFB staining (blue and
yellow arrow heads in Fig. 5 h, enlarged from Fig5. g & f).
Figure 1. T2 maps demonstrating the evolution of TBI lesion volumes (two upper rows) from representative low dose
methamphetamine treated (T) and saline treated (C) TBI rats. The two lower rows are also T2 maps, which demonstrate the evolution of
ventricular expansion for treated (T) and control (C) rats. Although the T2 maps obtained at 6 weeks after TBI showed smaller lesion and ventricular
volumes in the treated rats (the 1st and 3rd rows) compared with the control rats (the 2nd and 4th rows), no statistically significant differences were
found between the treated (n= 10) and control (n= 10) groups during the 6 weeks after TBI.
doi:10.1371/journal.pone.0061241.g001
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Discussion and Conclusions
This study demonstrated that low dose methamphetamine
treatment starting at 8 hours after traumatic insult in rats
significantly improved the recovery of behavioral functions in rats
by lowering mNSS and foot-fault scores after TBI, compared with
saline treatment. The treatment promoted neuronal recovery after
TBI, which was detected by MRI measurement of FA and
confirmed by immunohistochemical outcomes. The mean relative
FA values of the TBI recovery area exhibited significant increases
in the treated group at 5 and 6 weeks after TBI, compared with
the control group (p,0.03). The increased FA, indicating a more
reorganized white matter, may contribute to the functional
recovery after TBI in rats.
FA values have large variations dependent on the location of the
ROI in rat brain. Using the normalized FA, referred to as, pre-
TBI FA values, of the same ROI and the same animal, may
provide a more precise measure of white matter changes after TBI
in rat with or without treatments, since each ROI location differed
among the animals.
Based on the evolution of T2 values measured from all animals
in the study, it was reasonable to demarcate TBI damaged
cerebral tissue into core and recovery tissue by using T2 maps
obtained at 24 hours and 6 weeks after TBI. Fig. 2 d indicates that
T2 values of cerebral tissue in core ROI, independent of treatment
after TBI, increased from 1 week after TBI and then retained
elevated values, while T2 values of cerebral tissue in recovery ROI
decreased during the first week after TBI and remained the same
for 6 weeks. T2 values were very similar and no differences were
observed between the treated and control groups for either core or
recovery ROIs, respectively. Meanwhile, T2 values of cerebral
tissue exhibited significant differences (p,0.05) between the core
and recovery ROIs starting at 2 weeks after TBI for both groups.
Furthermore, T2 values of cerebral tissue from the core ROI
approached the T2 values of cerebral spinal fluid, and T2 values
from recovery ROI tended towards pre-TBI values. These results
indicated that cerebral tissue in the core ROI may be irreversibly
damaged after TBI, independent of methamphetamine or saline
treatments, which suggest that effective treatment of TBI may be
attributed to improved biophysical functions of cerebral tissue in
the recovery region.
MRI measurements of T2 maps did not detect the therapeutic
effects of the low dose methamphetamine treatment on reducing
lesion volume (core size) and ventricular expansion up to 6 weeks
after TBI in rat, although the mean values of lesion volume and
expansion rate of ventricular volume were decreased (p = 0.20 for
lesion volume and p= 0.32 for ventricular volume) in the treated
group as compared to the control group (Fig. 2 a & b). This result
was consistent with histological H&E measurements of TBI lesion
volumes. The neuroprotective effect of the low dose methamphet-
amine treatment of stroke is dose and time dependent [18]. A prior
study indicates that immediate treament of embolic stroke in rats
Figure 2. Lesion (A) and ipsilateral ventricular (B) volumes measured on T2 maps after TBI were charted for both treated (n=10) and
control (n=10) rats. Although the lesion and ventricular volumes were smaller in the treated rats, i.e. evident at 4 weeks for lesion and 3 weeks for
ventricle after TBI, than that in the control rats, no statistically significant differences were found between the two groups during the 6 weeks after
TBI. Normalized FA values (C) of recovery area demonstrated significant differences between the groups starting 3 weeks after TBI in rats. T2 values of
both core and recovery regions (D) did not show statistical differences between the two groups in 6 weeks after TBI; however, significant differences
were observed between core and recovery regions starting 2 weeks after TBI for all rats.
doi:10.1371/journal.pone.0061241.g002
MRI of Methamphetamine Treated TBI Rats
PLOS ONE | www.plosone.org 5 April 2013 | Volume 8 | Issue 4 | e61241
with methamphetamine for 24 hours at a dose of 0.1 mg/kg/hr,
or treatment initiated at 12 hours with a dose of 1.0 mg/kg/hr did
not reduce infarct volume [18]. Thus, the curent results in TBI are
consistent with the previous results, that no statistical neuropro-
tective effects were observed in the delayed methamphetamine
treatment in stroke. Expansion of the ipsilateral ventricular volume
after brain injury may indicate the loss of cerebral tissue, and
ventricular volume is a sensitive MRI index of brain atrophy after
stroke in rats [38,39]. In previous experimental studies of embolic
stroke, therapeutic effects of delayed Erythropoietin treatment in
adult rats or Sildenafil treatment in aged rats were detected
starting at 4 weeks or 6 weeks after stroke by the reduced
expansion rate of the ipsilateral ventricular volume demarcated
using MRI T2 maps, respectively [38,39]. For TBI rats,
experimental studies demonstrated a significant increase of lateral
ventricular volume at one year [40], and a significantly reduced
increase of lateral ventricular volume starting at 3 weeks post TBI
in bone marrow stromal cell treated rats, compared to saline
treated rats [20]. The results of the present study, thus, suggest that
methamphetamine treatment, initiated at 8 hours after TBI with
the selected dose (0.05 mg/kg/hr), does not reduce brain atrophy
within 6 weeks post traumatic insult.
The methamphetamine treatment of TBI rats in the present
study does not have significant effects on neuroprotection, but
enhances neurorestoration (neuronal and functional improve-
ment), similar to the delayed pharmacological treatments of stroke
in rats [38,39]. As in stroke studies [23,37–39], the delayed
treatments of TBI promoted neurorestorative process in cortical
tissue, such as axonal density and reorganization, which fosters
improved behavioral function. Without reducing lesion volume,
cell-based treatments of stroke in rat also improved functional
recovery from the short term (4 weeks) to the long term (1 year)
[41,42]. Therefore, the delayed low dose methamphetamine
treatment of TBI in rats may improve functional outcome by
enhancing biophysical functions of cerebral tissue in the recovery
region, although the treatment did not reduce lesion volume and
brain atrophy within 6 weeks post TBI.
Extensive axonal degeneration is the common result of
traumatic brain injury [4,6]. Injury, however, inversely induces
axonal sprouting [43,44], and new synaptic connections and
myelination are present in both injured and neighboring regions
[45]. White matter is reorganized, especially in the areas of the
corpus callosum. Proper treatment of TBI may enhance brain
reparative processes [19,20], similar to stroke [23,38,39]. MRI FA
Figure 3. Measurements of densities of MAP-2 staining (A), SMI-32 staining (B), and BLFB staining (C), demonstrated that low dose
methamphetamine treatment of TBI significantly increases neurons density and axonal reorganization in the ipsilateral
hemisphere in rats. However, no differences were found for synaptophysin staining (D). No differences were found with immunohistochemical
density stainings in the contralateral hemisphere of rat brain after TBI.
doi:10.1371/journal.pone.0061241.g003
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was able to monitor well-reorganized white matter recovery, and
similar results have been described for the detection of white
matter recovery after treatment of stroke in rats [19,23]. In the
present study, our data demonstrated a remarkable increase in FA
of the white matter extending from the corpus callosum to the
boundary of the TBI lesion in the treated animals, in contrast to
the controls (Fig. 2 c), suggesting that low dose methamphetamine
treatment facilitates white matter reorganization involving the
corpus callosum.
FA may be unable to detect white matter reorganization when
the white matter fiber bundles cross, and FA merely expresses an
overall lower value because of the assumption of a Gaussian
diffusion inherent to the tensor model [46–48]. Solving the
orientation distribution function (ODF), which is used to describe
the directionality of multimodal diffusion in regions with complex
fiber architecture, permits more accurate detection of crossing
fibers [26,36,49]. This calculation involves a complex set of Q-
space DTI analysis, including diffusion spectrum imaging (DSI)
Figure 4. Functional tests demonstrated that low dose methamphetamine treatment significantly lowered mNSS (A) and reduced
foot faults (C: forelimb; D: hindlimb) in treated rats starting at 1 week after TBI. However, no differences were observed in Morris water
maze test (B) between the treated and control rats.
doi:10.1371/journal.pone.0061241.g004
Figure 5. An ex vivo MRI scan of a control rat q-ball map (A), which is enlarged (B) to view fiber crossing, showed few crossing fibers
(blue and yellow arrow heads) surrounding the TBI lesion core (E, cyan arrow). Both SD (C) and FA (D) maps detected the reorganized
white matter (blue and yellow arrow heads), which was consistent with BLFB staining (blue and yellow arrow heads in H; G: 46enlarged, red frame in
F; H: 106 enlarged, yellow frame in G).
doi:10.1371/journal.pone.0061241.g005
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[49], Q-ball [26] and persistent angular structure MRI (PASMRI)
[36]. In addition, diffusional kurtosis imaging (DKI) has been
introduced as a quantitative measure of the degree to which the
diffusion displacement probability distribution deviates from
a Gaussian form [50]. Indeed, DKI has been shown to provide
the information necessary to solve the ODF [51], whereas the
apparent kurtosis coefficient (AKC) can provide additional in-
formation on neural tissue micro-architecture [52], such as cellular
compartments and membranes, and AKC is more sensitive to
axonal density than orientation. Generally, DKI acquires images
with multiple b-value shells but with less direction than Q-ball
does, thus DKI provides favorable quantitative diffusion proba-
bility distribution, but Q-ball with a higher resolution angular
distribution. Therefore, the advantage of the SD map is that it can
be concomitantly obtained with a fiber crossing map using a single
measurement of Q-ball, while angular resolution of AKC is
generally too low to simultaneously produce a high quality fiber
crossing map. Both SD and AKC are sensitive to early stages of
white matter reorganization, and are superior to FA in the
detection of white matter reorganization with prominent crossing
axons [19,37]. However, solving the ODF requires high angular
resolution MRI data. The more directions the MRI scan contains,
the more accurate the ODF produced, and the more time the
MRI scan takes. Thus, very high angular resolution DKI and Q-
ball DTI are rarely employed for in vivo studies.
SD and FA should show a similar pattern if the white matter
bundle is well organized along a single direction [19]. The BLFB
stained slices and MRI fiber crossing maps of the current study
(Fig. 5) showed that the majority of axonal bundles were well
organized into a single direction and are present only in small
areas with crossing bundles. These results indicated that fiber
crossing, at least 6 weeks after TBI, has a minor affect on FA
values of TBI recovery cerebral tissue. Thus, the lower FA values
in control rats than in the methamphetamine treated rats were
primarily caused by fiber density rather than by fiber crossing,
which was also alternatively confirmed by the significant Pearson’s
correlation (R= 0.54, p,0.02) between the FA measured 6 weeks
after TBI and histological BLFB measurements. The temporal
profiles of FA measurements (Fig. 2 c), suggested that low dose
methamphetamine treatment after TBI improves white matter
reorganization from 5 weeks after brain traumatic insult in rat,
compared with saline treatment.
Immunocytochemically, SMI 32 visualizes neuronal cell bodies,
dendrites and some thick axons, especially for neocortical
pyramidal neurons [53]. The significant increase of SMI-32 and
MAP-2 immunoreactive proteins, thus, suggests that metham-
phetamine treatment after TBI promotes the development of
dendrites. Meanwhile, the treatment also increased axonal
myelination, which was indicated by a significant increase of
BLFB immunoreactive axons in the ipsilateral hemisphere of TBI
rats. Therefore, these results indicated that methamphetamine
treatment improves neuronal recovery in TBI rats. However, the
synaptophysin data did not show any significant differences
between the treated and control rats, and the reason for this is
unclear.
Neuronal fiber reorganization after injury may play an
important role in fuctional recovery [41,42]. We found that 12
hour post stroke methamphetamine treatment at an infusion dose
of 1.0 mg/kg/hr for 24 hours in rats did not reduce infarct volume
examined at 7 days post injury, but, did improve neurological
scores in rats compared with saline treated controls [18]. In the
present study, our data demonstrated that low dose methamphet-
amine treatment of TBI reduces neither TBI lesion volume, nor
ventricular volume expansion, but, the treatment increased white
matter reorgnization, and hence, functional outcomes over a 6
week period after the TBI insult, compared to the control. This
result indicated that, as in the stroke model, delayed administra-
tion of very low dose methamphetamine has a minor effect on
neuroprotection, but yet still improves functional outcome in TBI
rats; which implies that reorganization of white matter may be
a major contributor to the functional recovery after brain injury.
The improved functional outcome with low-dose methamphet-
amine treatment also suggests that a significant increase in cortical
neuron activity in methamphetamine treated rats may enhance
sensorimotor functions, such as mNSS and foot-fault, without
improving cognitive function, as measured with the Morris Water
Maze test.
Using a different treatment protocol (0.845 mg/kg in bolus
injection, followed by 0.5 mg/kg/hr624 hrs infusion), timing
(3 hrs after TBI) and traumatic model [15], methamphetamine
treatment of TBI in rat was recently reported to improve not only
behavioral function in mNSS and foot fault tests, but also cognitive
function in the Morris Water Maze test 27 days after TBI insult.
Thus, combined with our present results, these data suggest that
the functional recovery after TBI in rats is dependent on dose and
time of methamphetamine treatment.
Methamphetamine is a potent psychostimulant that alters the
release and reuptake of dopamine, norepinephrine, and serotonin
[18]. In a transient middle cerebral artery occlusion model in the
rat, low dose of methamphetamine was found to mediate
neuroprotection through activation of a dopamine-PI3K-AKT
signaling pathway [18]. Similar results were found in a rat lateral
fluid percussion injury TBI model [15]. In the current study, the
mean TBI lesion volume in the treated group (25.51612.14 mm3)
was smaller than that in control group (32.4969.45 mm3)
although it did not reach statistical significance at 6 weeks after
TBI. We note, that the dose used in the present study was one
tenth of that used in the earlier studies, and therefore a higher dose
may produce a more robust effect [15]. Therefore, the very low
dose methamphetamine treatment of rat initiated at 8 hours post
TBI may provide a minor neuroprotective effect. Several previous
studies have demonstrated increased axonal density detected by
MRI FA and corresponding BLFB staining [19,23,37–39], and
cell-based treatment 6 hours after TBI demonstrated neurores-
torative effects compared with untreated animals [54]. Thus,
based on the MRI FA detected increase of axonal bundles and
confirmed with corresponding BLFB staining data, the low dose
methamphetamine treatment may promote neurorestorative
effects, since it induces white matter reorganization and functional
recovery after TBI. However, the exact mechanisms underlying
the therapeutic effects of low-dose methamphetamine for TBI are
not clear, and merit further investigation.
In summary, very low dose (a bolus injection of 0.42 mg/kg
followed by an infusion of 0.05 mg/kg/hr for 24 hrs) metham-
phetamine treatment starting at 8 hours after TBI in rats did not
significantly reduce lesion volume and brain atrophy, however, it
did affect white matter structure and remodeling, and neurological
function at 6 weeks after traumatic insult. In addition, MRI
provided sensitive and insightful indices underlying this functional
benefit.
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